Role of Stemloop D in Terminally Deleted Coxsackievirus B3 Replication by Jaramillo, Lee K.
University of Nebraska Medical Center 
DigitalCommons@UNMC 
Theses & Dissertations Graduate Studies 
Spring 5-7-2016 
Role of Stemloop D in Terminally Deleted Coxsackievirus B3 
Replication 
Lee K. Jaramillo 
University of Nebraska Medical Center 
Follow this and additional works at: https://digitalcommons.unmc.edu/etd 
 Part of the Laboratory and Basic Science Research Commons, Molecular Biology Commons, and the 
Virology Commons 
Recommended Citation 
Jaramillo, Lee K., "Role of Stemloop D in Terminally Deleted Coxsackievirus B3 Replication" (2016). 
Theses & Dissertations. 103. 
https://digitalcommons.unmc.edu/etd/103 
This Thesis is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has 
been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. 
For more information, please contact digitalcommons@unmc.edu. 
 
ROLE OF STEMLOOP D IN TERMINALLY DELETED COXSACKIEVIRUS B3 
REPLICATION 
by 
Lee K. Jaramillo 
A THESIS 
Presented to the Faculty of 
the University of Nebraska Graduate College 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
 
Pathology & Microbiology Graduate Program 
 
Under the Supervision of Professor Nora M. Chapman 
 
University of Nebraska Medical Center 





Steven Carson, Ph.D. Steven Tracy, Ph.D. Nora Chapman, Ph.D.
i 
 






















Master’s Thesis  LEE JARAMILLO 
Acknowledgement 
 First and foremost, I need to thank my mentor Dr. Nora M. Chapman, for her incredible 
patience and support over the past several years. Through all the trials and tribulations, 
she remained a rock during an otherwise tumultuous endeavor. There were many times 
I would have liked to have thrown in the towel, but she never gave up on me and for 
that I owe her everything. 
 I would like to thank my graduate committee members Dr. Steven Tracy and Dr. Steven 
Carson for their time and advice they willingly provided each time I asked. 
 I have to thank Dr. Shane Smithee for his help in both my paper and in the lab. 
 Lastly, I’d like to thank my family and lovely wife Jackie Jaramillo. They never gave up on 


















































Master’s Thesis  LEE JARAMILLO 
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Advisor: Nora M. Chapman 
Coxsackievirus B3 (CVB3) is an enterovirus with no known form of latency. However, assays 
designed to detect enteroviral RNA have shown that CVB3 RNA can persist for weeks beyond 
the acute infection both naturally and experimentally. Our previous work with coxsackievirus 
revealed an inhibited version of enteroviral replication where the progeny virus, termed 
terminally deleted (TD) virus, was missing a maximum of 49 nucleotides from the beginning of 
the 5’ non-translated region (NTR). The largest terminally deleted virus, TD50, effaced stem a, 
stemloop b, and stemloop c from the secondary structure, the cloverleaf. We hypothesized that 
further deletion beyond those first 49 nucleotides (nt) would disrupt stemloop d and prevent 
alternative binding of replicative machinery to the point of lethality. Plasmid DNA designed to 
create functional wildtype CVB3, was used as a template to create two novel constructs: TD57 
and TD78. The mutant plasmids would transcribe infectious viral RNA missing up to 56nt and 
77nt from the start of the 5’ NTR respectively. After transcription, the mutant RNA was 
transfected into HeLa cells and incubated for three days. Using RT-PCR we prove that despite 
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Chapter 1: Introduction 
What is an Enterovirus 
Enteroviruses belong to the family Picornaviridae. The enterovirus genus comprises 12 
viral species including the prototypical enterovirus, Poliovirus. These viruses are classified 
according to serotype or the ability for neutralizing antibody to affect an isolated virus often 
identified by the most conserved genetic sequence of the capsid structure [1-3]. Enteroviruses 
contain only one copy of a single stranded positive sense RNA molecule within a naked 
icosahedral capsid [4]. The capsid structure consists of 60 protomers made from 3 viral proteins. 
The capsid structure includes a canyon depression which is the site of the virus interaction with 
the host cell receptor [5, 6]. Interaction with the receptor causes a conformational change 
allowing the genome to egress into the host cytoplasm where translation, replication, and 
assembly of the viral particle will occur. 
History of disease 
Enterovirus infection can cause a range of diseases based on the infected organ, such as 
non-septic febrile illness, respiratory illness, acute hemorrhagic conjunctivitis, type 1 diabetes, 
myocarditis, meningitis, pancreatitis, paralytic poliomyelitis, and dilated cardiomyopathy to 
name a few [4]. In temperate regions of the world CVB infections mainly occur during the 
summer and fall, but can vary depending on the serotype [4, 7-11]. Coxsackievirus B 1, 3, and 4 
exhibit an epidemic pattern where activity can increase at irregular patterns [12, 13]. Still, 
coxsackievirus infections are generally asymptomatic or subclinical [4].  
The most notable disease, paralytic poliomyelitis, is contracted from poliovirus which is 
a virus with a long history in medicine. The first documented case of polio was by the physician 
Michael Underwood in 1789 when he was treating a young child for paralytic poliomyelitis [14]. 
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Paralytic poliomyelitis is one of the more severe diseases that enterovirus can cause, but most 
of the research regarding the disease did not come until an epidemic of polio broke out in the 
late 19th century. It is believed that the cause of this outbreak was from an increase in public 
sanitation which in turn caused the general population to encounter the virus for the first time 
at a later age [15]. Prior to this time typical infection was between the age of 0 and 12 months 
old, a time when protective antibodies acquired from the mother were still circulating [15].  
Research into the epidemic and the disease resulted in a number of landmark 
discoveries, one of which being the virus itself by Landsteiner and Popper [16]. Discovery of the 
viral agent furthered research in this area which would later bring about the polio vaccine. The 
first polio vaccine developed for human protection was an inactivated form of the virus by Salk 
[4]. This first vaccine was an incredible step on the road to polio eradication and was only 
bolstered by the discovery of a live form of the polioviruses by Sabin [4]. The live form of the 
virus was heavily attenuated, but still sufficiently replicated for a robust immune response. The 
normal processes of the virus could continue without affecting the host, which in turn generated 
a much more robust immune reaction that could last longer than the inactivated form of the 
vaccine could create [4]. Since advent of the vaccine there are now only three countries that 
have never interrupted transmission of the wildtype virus [17]. 
Despite our success in vaccination attempts, there are still many enteroviruses for which 
there are no vaccines and still affect millions of people annually. The virus is typically transferred 
via fecal-oral tract and can cause illness in the upper and lower respiratory system. 
Coxsackievirus A16 is the most common cause of hand, foot, and mouth disease in the United 
States and Coxsackievirus A24 along with enterovirus 70 have been associated with outbreaks of 
conjunctivitis. Echovirus, specifically 13, 18, and 30 have caused outbreaks of viral meningitis in 
the United States which can be life threatening. In regards to the rest of the world, enterovirus 
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71 has caused large outbreaks of hand, foot, and mouth, including cases of neurologic disease, 
worldwide and enterovirus D68 caused a nationwide outbreak in 2014 in the United States [18]. 
Infections with the virus are acute events, but under the right conditions can become chronic in 
a persistent infection [19]. In cases where myocarditis was ruled the cause of death in human 
patients, enteroviral RNA was often recovered when checked [20, 21]. 












Figure 1: Brief overview of the enterovirus life cycle. 
Receptor structure can vary from virus to virus, such as with poliovirus and 
coxsackievirus that use immunoglobulin like receptors, [5] but minor group human rhinoviruses 
can use VLDL-R for a receptor [22-24]. Each enterovirus species uses a host receptor that causes 
a conformational change of the capsid allowing the virus to be internalized via endocytosis and 
release the genome from the capsid. Rossman proposed that the receptor binds into a canyon 
structure found on the surface of the virus, as in coxsackievirus that encircle each twelve 5-fold 
vertex, each being inaccessible to the host immune system [6]. In the case of coxsackievirus B, 
binding of the CAR receptor can be preceded by binding of a secondary receptor known as DAF 
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or CD55 which can aid in the binding of CAR [25-27]. In poliovirus a similar interaction takes 
place using Poliovirus Receptor (PVR) [28]. 
The interaction with the enterovirus with its receptor leads to the formation of the A-
particle that is characterized by a partial exposure of the RNA and release of the internal VP4 
from the virus [29, 30]. Enteroviral particles have been shown to internalize using a number of 
methods. CVB3 has been shown to internalize using clathrin [31], whereas CVB4 has shown 
internalization using a lipid raft [32], and CVB3-RD variant that uses DAF, internalization using 
caveolin-1 [25]. It is believed that the egress of the genome into the cytoplasm is accomplished 
using the viral protein 4 that is internally located until the cellular receptor binding event [33-
35]. Eventual translation and replication of the viral genome will allow for packaging and release 
from the host cell. 














Figure 2: Genome organization of Coxsackievirus and subsequent protein processing [36]. 
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Upon entry of the host cytoplasm, the RNA is translated via a cap-independent 
mechanism by host ribosomes using an Internal Ribosome Entry Sequence (IRES)[5]. This type of 
RNA structure is not unique to enteroviruses, varies from species to species, but all act as a way 
to guide the host ribosomal machinery to the site of initiation without the presence of a cap 
structure. Only one open reading frame exists in the small viral genome and from it a number of 
structural and nonstructural proteins are expressed. The open reading frame is divided into 
three general regions: P1, P2, and P3 with P2 broken down further to A-C and P3 A-D.  
P1 
From P1 come the capsid proteins, while P2 and P3 create a variety of nonstructural 
proteins used to replicate the genome. When translated, P1 will generate VP1, VP3, and VP0. 
VP0 will eventually be cleaved into VP4 and VP2 via a catalytic post-packaging step during viral 
assembly [5]. The structural proteins VP1, VP2, VP3, and VP4 are used to make the viral capsid. 
VP1, VP0, and VP3, will combine to make a protomer. This single protomer combines with other 
protomers to complete the capsid, which upon forming, undergoes an autocatalytic cleavage to 
then form VP2 and VP4 with VP2 on the outside and VP4 on the inside. The final infectious 
capsid contains the viral protein genome-linked (VPg) covalently linked to the viral genome, with 
which the RNA will be primed for transcription using a virally encoded RNA dependent RNA 
polymerase (RdRp)[5].  
P2 
P2 proteins mainly aid in the processing of the viral genome and remodeling of the host 
cell. The first P2 protein translated is protein 2A which is a cysteine protease that cleaves the 
junction between P1 and P2 after translation [37]. 2A also cleaves eIF4G, host nucleoporins, Poly 
A Binding Protein (PABP), and TBP: a number of host factors that naturally promote the creation 
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of host proteins and when cleaved can still be used by the enterovirus for translation and 
replication [38]. Viral protein 2B or 2BC disrupts the Golgi complex and secretory pathway, but 
also plays a role in virally produced membranous vesicles that has yet to be fully elucidated [39]. 
2C has ATPase activity, RNA helicase activity, chaperone activity, and encapsidation involvement 
[40]. These functions of 2CATPase have been shown to be critical in vitro in enterovirus 71 and 
coxsackievirus A 16 [41, 42]. 
P3 
The proteins of P3 are directly involved in the replication of the genome. The P3 region 
is processed in two ways: the major and minor pathway. The major pathway yields proteins 3AB 
and 3CD. The protein 3AB has been shown to stimulate the activity of the RNA dependent RNA 
polymerase [43-45], but also may play a role in the formation of vesicles. Protein 3CD is a 
protease used to cleave the polyprotein and an RNA binding protein PABP [46, 47]. Translation 
via the minor pathway yields proteins 3A and 3BCD. 3A has been shown to disrupt the trafficking 
of the ER to Golgi signaling, while 3BCD will be further processed into 3B, 3C, and 3D [39, 48-50]. 
While 3C is the major protease that processes P2 and P3 proteins, 3D the RdRp, and 3B (or VPg) 
are intimately involved in the replication of the viral genome. 
Wildtype Replication 
VPg 
Protein 3B is the protein primer used in transcription of the RNA genome during 
replication. Before priming replication, VPg is first uridylylated using the RdRp and a Cis-acting 
Replication Element (CRE) as a template [51]. In coxsackievirus, 3CD will bind the stem of the 
CRE structure located in the 2C region and 3D with VPg attached will “read” the AA residue 
found in the loop of the CRE. The CRE structure can be located in a number of different areas, 
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taking on different shapes and sizes, but will always have a double adenine with which it can 
prime the addition of the uracil to VPg [52]. Addition of the uridine nucleotides to VPg is 
believed to be accomplished by 3D using a slide-back mechanism [51]. Once the UU is added to 
the VPg, it can be used as a primer and anneal to the 3’ terminal AA of the negative strand viral 
RNA. 
3D 
Viral genome replication requires the function of the RNA dependent RNA polymerase 
or 3D. 3D is processed from P3 and again from 3CD [53]. 3D is essential for VPg uridylylation 
[54], initiation of the strands of viral RNA, and elongation of the viral RNA during viral RNA 
synthesis [55]. 3D polymerase is able to effectively transcribe the positive stranded viral RNA to 
create a negative strand that can then be used as a template for additional positive strands of 
viral RNA [56]. Enteroviral RdRp’s have the same overall shape as other polymerases and have a 
right-hand conformation with a thumb, finger, and palm domain [57]. More to the point, 
rhinovirus, poliovirus, and coxsackievirus have very similar 3D structures [58]. The 3D fingers-
domain is important for maintaining stable and processive elongation and is involved in binding 
incoming template RNA [59]. While flavivirus 3D can initiate polymerization de novo, poliovirus 
and coxsackievirus need VPg as a primer and by binding the protein primer with uridylylated 3B, 
the negative strand of viral RNA is first transcribed [60].  
Circularization 
VPg will prime the replication process, but both ends of the viral RNA and the 
interacting proteins are required to be in close proximity of one another and it is believed that 
this is accomplished by circularizing the positive strand [56]. Computer mapping of the 7500nt 
genome show complicated structures from beginning to end. Three locations in particular have 
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seen increased interest, in relation to replication, due to the complicated secondary structures 
that they form and the direct contribution to the efficient viral replication: 5’ cloverleaf, 3’ 
cloverleaf, and the CRE. A ternary complex composed of 3D, 3CD, Heterogeneous nuclear 
ribonuclear protein (hnRNP C), Poly-C Binding Protein, and domain I of the 5’ end of the positive 
strand forms to allow interaction of the 5’ end and 3’ end PABP which binds multimers of 
adenine such as the polyA tract of the genome [61-63]. The VPg bound 3D associates with the 3’ 
end of the positive stranded RNA and begins elongation of the negative strand. The first round 
of transcription yields the negative strand of viral RNA and will be the new template for a 
number of positive strands. The new negative strand and template positive strand form a 
heteroduplex of positive and negative stranded viral RNA [64, 65].  
Replicative Form 
This duplex creates the hypothetical heteroduplexed positive and negative strand of 
viral RNA termed the replicative form (RF) which is produced in the stage before exponential 
viral RNA replication [64, 65]. It is believed that a combination of host proteins and viral proteins 
are involved to unwind the RF, namely the ternary complex, 2C, and hnRNP C [56]. Newly 
uridylylated VPg attached to 3D, 2C, and hnRNP C proteins bind the newly synthesized 3’ end of 
the negative strand RNA while the ternary complex reforms on the 5’ end of the positive strand 
in the heteroduplexed RF [62, 66]. While the mechanism of action has yet to be fully elucidated, 
the RF is unwound making room for binding of the uridylylated VPg bound 3D to begin 
elongation [67]. 
Replicative Intermediate 
Elongation of the new positive strand begins at this point, but before completion of the 
first strand of positive stranded RNA, it is hypothesized that multiple positive strands of RNA are 
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initiated on that same negative strand of RNA, creating a new structure of RNA referred to as 
the replicative intermediate (RI) [56]. Formation of the RI begins an exponential generation of 
newly synthesized positive stranded viral RNA. The ratio of positive to stranded RNA has been 
demonstrated to be 40:1 to 70:1 with the newly synthesized strands being used for 
transcription, translation, or packaging into empty capsids [68, 69]. 
Terminally Deleted Viruses 
The wildtype enteroviral replication process described above is an acute event, with 
symptoms and viral titers both climaxing and clearing in a few days [70]. That being said, 
enteroviral RNA or protein has been detected in patients presented with heart maladies [71-74]. 
Furthermore, coxsackievirus infection in mice can persist for long periods of time, even months, 
when infected with cardiovirulent strains [75-78]. It is believed that this persistent infection is 
permitted due to low-levels of replication averting detection by the host immune system. These 
naturally occurring enteroviruses were first identified in coxsackievirus B and shown to have a 
number of deletions to domain I, more specifically, the cloverleaf [79]. 
Cloverleaf 
The positive stranded EV RNA is flanked on each side by 5’ and 3’ non-translated regions 
that naturally form a number of secondary structures like the IRES and CRE, but also the 
aforementioned cloverleaf structure in domain I [80]. The cloverleaf, which typically is the 
binding site of the ternary complex in efficient replication, is modified in the case of the TDs. 
Terminally deleted viruses are shown to have a number of deletions on the cloverleaf structure 
with the largest being the removal of the first 49nt [79]. Because these viruses suffer the 
formation of an incomplete cloverleaf they are not found under normal experimental conditions 
possibly because they are outcompeted by wildtype replication. The initial replicative event 
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causing the creation of these TDs is thought to be an inaccurate initiation event during positive 
strand synthesis. Research has shown TDs generated in mice and in cell cultures lacking hnRNP C 
such as cardiomyocytes and pancreas islets [81].  
Cause of TDs 
As previously mentioned, hnRNP C is hypothesized to be involved in the initiation of the 
positive strand synthesis by unwinding of the RF. Inefficient priming of the new positive strands 
drops the ratio of positive to negative strands closer to 1:1 [79]. The positive to negative strand 
ratio is heavily unbalanced in efficient replication of the virus as stated earlier. The deletions 
found in these experiments affect only stem a, stemloop b, and stemloop c. Deletion into 
stemloop d has not been shown; possibly because stemloop d contains essential structural 
rearrangements critical to viral propagation. 3CD has already been shown to bind stemloop d 
and PCBP poly C region just beyond the opposite half of stem A [61-63]. This association led us 
to hypothesize that the structures such as the di-nucleotide bulge, the non-canonical base pairs, 
or the apical tetra loop are the minimum requirements for CVB replication. Our experiments 
show that deletion beyond the first 49nt produces viable virus: new TDs with further decreased 
replicative events. Removal of the di-nucleotide bulge and the complete elimination of stemloop 
d does not prevent CVB replication.  
Chapter 2: Methods and Results 
Generating the Terminally Deleted Viruses 
Hypothesis: 
The examination of size of TD genome deletions was assessed in several studies [79, 82, 
83]and no larger deletions than 49nt were found. 
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Figure 3: Stemloop d of domain I folded into the secondary structure known as the cloverleaf with the projected 
deletions noted by arrows. 
As shown in the figure above, the 5’ end of the CVB3 genome is shaped much like a cloverleaf, 
with three stem like structures formed by folding the RNA genome onto itself. Deletion of the 
first 49nt removes the stem and the first two leaves, but retains the third leaf, stem-loop D 
untouched. Mutational studies to the structures of the cloverleaf have targeted each of the 
three structures in stem-loop D [63, 84, 85] and in doing, showed a reduction in positive strand 
synthesis and a reduction in overall replication. With this in mind, we hypothesized that deletion 
beyond the first 49nt and into the cloverleaf, would be a lethal mutation. This is supported due 
to the findings that 3CD binds to stem-loop D [61] as part of the ternary complex. The research 
conducted as follows will show that deletion of the di-nucleotide bulge and the entire stem-loop 
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Growing the Starting Plasmid 
 
To generate the deleted cDNA genomes with an upstream T7 RNA polymerase promoter 
and a ribozyme which would cleave the T7 transcripts correctly, the plasmid pCMVT7r28 [81] 
was used as the cDNA basis for mutagenesis. The smallest 5’ terminal deletion was TD57, where 
the first 56nt from the 5’ end of the genome would be deleted. It was suspected that deleting 
past the first 50nt would fail to generate any replicating virus. The pCMVT7r28 plasmid was used 
to create both the fragment and vector of the mutant. E. coli (strain DH5α) containing the 
plasmid was grown on LB Broth Miller (Luria-Bertani) plates (prepared according to Becton, 
Dickinson and Company, Franklin Lakes, New Jersey) coated with 50µg/mL ampicillin.  Ampicillin 
was the selecting agent used to grow the pCMVT7r28 because the strain of E. coli used was not 
resistant to the drug and the plasmid provided the selective resistance. Single colonies would be 
picked from the plate and cultured in Terrific Broth, allowing for a higher density of bacteria in a 
shorter time period, (prepared according to Becton, Dickinson and Company, Franklin Lakes, 
New Jersey) again with 50µg/mL ampicillin. Cultures were processed using the QIAprep Spin 
Miniprep Kit (according to QIAGEN, Valencia, CA) where final elution was completed using 50µL 
DEPC treated sterile water. This kit is a streamlined version of an alkaline lysis where the target 
genome was purified from the remaining cellular debris using the QIAGEN columns. Plasmid 
concentration and purity was measured with a spectrophotometer and less than 1µg was run on 
a 1.0% agarose gel in 1xTAE stained with SYBR® Safe DNA Gel Stain (according to ThermoFisher 
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Waltham, MA) and visualized using a transilluminator. Two bands running at different positions 
was indicated relaxed and supercoiled plasmid DNA purified from the bacterial lysate versus 
bacterial genomic DNA. A larger 100mL Terrific Broth (ThermoFisher Waltham, MA USA) culture 
was grown from the single picked colony and processed using a QIAGEN Plasmid Purification 
Midi kit (according to QIAGEN) and eluted with 50µL DEPC treated sterile water. Again the 
samples were quantified using a spectrophotometer and observed on a 1% agarose gel before 
continuing.  Using the highly concentrated pCMVT7r28, ClaI was used to linearize the circular 
plasmid (New England Biolabs Ipswich, MA) at a site following the poly A tract at the 3’ end of 
the viral cDNA. Once linearized, the plasmid was then purified from enzymes and buffers using a 
standard ethanol precipitation with a final concentration of 0.625M ammonium acetate, 75% 
ethanol, and at least 2µL glycogen. The precipitation was then chilled in a -70°C freezer for 
30min. The DNA was then pelleted in a centrifuge for 15min at 16,000xg. The supernatant was 
removed and the remaining pellet was washed twice with 100% Ethanol. DNAs were air dried 
and suspended in 50µL of DEPC treated water. This standard precipitation protocol was 
important to remove any buffers and enzymes leftover from the digest that may interact with 
additional digests or PCR. The final product from the precipitation was run on an agarose gel just 
as described before to verify that the DNA was cut and all debris was removed. Mobility of the 
cut DNA would run at approximately 10kbp. Our preparations often contained a smaller 
bacterial plasmid separate from our product which (uncut) electrophoresed at a mobility similar 













The linearized plasmid was then further digested using Pst1 and Not1 (buffer and 
incubation as recommended by Invitrogen, Grand Island, NY). These two enzymes cut the 
genome in two places creating a smaller fragment with which to work. This template was used 
to amplify a product with the following primers (TD57RIBOZ1; E3) using Deep Vent DNA 
polymerase (New England Biolabs, Ipswich, MA) to decrease variation generated in polymerase 
chain reaction (PCR). Cycling followed this protocol: 94°C for 1 minute to denature, 60°C for 1 
minute to anneal primers, 72°C for 1 minute to elongate, 35 cycles of 94°C for 30 seconds, 61°C 
for 30 seconds, 72°C for 40sec, followed by 10 minutes at 72°C to finish any amplified product.  
Products were analyzed on 2.0% agarose gels in 1X TAE and purified on silica matrix 
minicolumns (Zymoclean™ Gel DNA Recovery Kit, Zymo Research, Irvine, CA). The gel recovery 
kit was preferred over an ethanol precipitation as it was believed that by excising the correct 




Image 1: Linearized 
pCMVT7r28 cut by ClaI 
run on an agarose gel. 
15 
 





















                
                  Figure 5: TD78 primer sequences as they apply to the 5’ cloverleaf ribozyme. 
Subsequent amplification of the 0.55kb product with TD57RIBOZ2 and E3 followed the 
pervious protocol with the modification of using an annealing temperature of 56°C and eventual 
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purification using the DNA Clean & Concentrator™-5 (Zymo Research, Irvine, CA). The 0.55kb 
product of the second amplification was extended by amplification with RIBOZPCRT7 and 
RIBOZRETURN using an annealing temperature of 60.9°C and then purified.  This product of 
0.56kb contained a 5’ terminal Not1 site and an internal PstI site allowing the generation of a 
576bp product by digestion with these enzymes (Invitrogen and New England Biolabs). The 
digest was run on a 1% agarose gel and the vector band was excised and cleaned using the 
Zymoclean™ Gel DNA Recovery Kit with manufacturer recommendations. The vector DNA was 
then digested with shrimp alkaline phosphatase SAP according to factory recommendations to 
remove the phosphates still attached to the ends, making the fragment incapable of self-
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Cloning TD57 
 
pCMVT7r28 was digested with NotI and PstI just as the fragment above, to create the 
appropriate ends for insertion of the newly generated fragment. This pCMVT7r28 vector and the 
newly generated TD57 fragment were ligated together using T4 DNA ligase (according to 
Promega Madison, WI). The ligated product was ethanol precipitated as described above. This 
plasmid was then transformed into E. coli cells using the Mix & Go Competent Cells - Strain 
Zymo 5α (according to Zymo Research Irvine, CA). DNA was prepared from cultures of individual 
colonies using the QIAprep Spin Miniprep Kit. The DNA isolated from the kit was then digested 
using HaeII (New England Biolabs Ipswich, MA) and observed by running a 2.0% agarose gel. 
HaeII was chosen as the restriction enzyme because the resulting agarose gel would show 4 
bands (6.2kbp, 1.5kbp, 370bp, and 2.2kbp) while the TD57 and TD78 plasmids would show only 
3 bands (1.5kbp, 370bp, and 8.5kbp). While some of the bands would be difficult to observe on 










Wells with bands at 10kbp, 1.5kbp, and 0.4kbp were sequenced with primer SReturn. 
When these samples returned with the correct sequence, the original colonies were grown in 
100mL cultures and sequenced a final time using both pCMVPrimer and E1. Primer pCMVPrimer 
was used to read in the opposite direction and E1 is a primer that is further removed from the 
5’NTR with a more familiar sequence. 
Culturing HeLa cells 
HeLa cells (American Type Culture Collection, Manassas, VA; CCL2) were cultured in 
100mm culture dishes at 37°C, 5% CO2 in 10mL of DMEM with 10% Fetal Bovine Serum (FBS) 
and 1% gentamycin. FBS is used in media to provide the necessary nutrients needed for 
continued cell growth while gentamycin provides a selecting agent and means of preventing 
bacterial and fungal growth. Cells were also cultured in 6-well plates. 
Image 2: A sample gel 
showing the results of 
the HaeII digest used to 
identify TD57 and/or 
TD78. This particular gel 
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Transfection and Infection of TD57
 
The newly generated TD57 plasmid was linearized using a ClaI digest and purified with 
an ethanol precipitation. The linearized plasmid was then transcribed into RNA using T7 
RiboMAX (according to Promega Madison, WI) and purified using a LiCl precipitation (addition of 
2µL glycogen and 4M LiCl to a final concentration of 2M at -20°C for 1 hour). RNA was pelleted 
(16,000xg for 20min), the resulting pellet was washed with 100% EtOH, and finally suspended in 
sterile DEPC treated water. Transfecting 2µg of RNA into (approximately 3.0x105 cells in each 
well of a 6-well plate) the HeLa cells was done using Transmessenger Transfection Reagent 
(according to QIAGEN) per manufacturer’s instructions. After transfection, cells were incubated 
for 3 days. Alongside this transfection, three controls were also transfected: the original 
pCMVT7r28 plasmid (cut with ClaI) was transcribed, control MS2 bacteriophage RNA, and a 
water control. The transcribed pCMVT7r28 RNA would act as a positive control since it has been 
shown that the 28 plasmid generates infectious virus and kills the transfected monolayer. The 
MS2 RNA can’t create bacteriophage without a prokaryotic host and is a control for toxicity from 
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introducing foreign RNA into HeLa cells. Two additional controls were also used, a negative 
control had no RNA in the transfection mix and the tissue culture control would be a well free 
from any transfection reagents. 
Detecting the Terminally Deleted Virus Post-Transfection 
 
Viral Preparation from HeLa Cells 
Virus was prepared from cells by three rounds of freeze-thaw lysis in 500µL 0.1M NaCl. 
Freeze and thaw of the monolayer causes the cells to lyse. The lysed material was then passed 
through a 0.22µm filter that allows only the passage of virus and small organelles eliminating 
intact cells. After filtration, 50µg/mL RNase was added to each tube and incubated for 30min 
and spun down to degrade cellular RNA (non-encapsidated RNA).  The supernatant was then 
processed with the Direct-zol™ RNA MiniPrep (according to Zymo Research Irvine, CA) without 
the addition of DNase. Because it was believed that very low levels of viral RNA would be 
produced additional cleaning steps could reduce the yield and we did not want to risk carry over 
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of DNase in the subsequent reverse transcription (RT) reactions. Trizol was the preferred 
method of RNA extraction and by using the kit we could eliminate some possible sources of 
contamination. 
RT-PCR and PCR for Viral RNA 
The RNA eluted from the column was used in an RT reaction facilitated by the Improm-II 
kit (according to Promega Madison, WI). RT PCR reactions were primed with E1 (Table) and the 
subsequent PCR using the Promega GoTaq® Green Polymerase Master Mix used primers S5 and 
SReturn to detect viral RNA. The same set of RT-PCR and PCR reactions were used for the cell 
lysate, media, and controls. A negative control using water and a positive control using 
pCMVT7r28 plasmid were cycled alongside the products from the transfection as well as an RT-
PCR control with only water. The products from the S5/SReturn PCR were run on a 2.0% agarose 
gel alongside HiLo DNA ladder (Minnesota Molecular) and stained using SYBR® Safe DNA Gel 
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The resulting gel showed that encapsidated RNA could be detected. A duplicate plate 
subjected to the same transfection conditions was fixed with glacial acetic acid and water 







When dried, the plate was imaged above to show how wildtype virus created from the 
pCMVT7r28 showed cytopathic effect (CPE), whereas virus produced from TD50 and TD57 does 
not show CPE after three days of incubation despite being able to detect viral RNA via RT PCR. 
TD78 
The procedure for TD78 was similar to what was described above except the primers 
used for the initial creation of the fragment were TD78RIBOZ1, TD78RIBOZ2, 
TD78RIBOZRETURN. After creating the TD78 mutant the same procedures and PCR reactions 
were run and visualized on a 2.0% agarose gel. The same negative and positive controls were 




Image 4: A secondary 6-
well plate created to 
show despite a successful 



























Image 6: The above image from a secondary 6-well plate, stained with crystal violet, shows that TD78 does not cause 
CPE. 
Chapter 3: Discussion 
In this study, we have constructed two novel plasmids. We found that when these 
plasmids were transcribed into RNA and transfected into a susceptible cell line, they were 
capable of generating encapsidated virus. Furthermore, we showed that the virus produced 
from these RNA transfections did not regenerate the 5’ terminal deletions cloned into the 
starting plasmids. The overall structure formed by the 5’ cloverleaf in enteroviruses is critical to 
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efficient viral replication; continued replication despite the ability to form this structure could 
represent an alternate method used during viral replication or the current model of enteroviral 
replication is incomplete. It has been hypothesized by Smithee et al. that the alternate method 
is actually a randomized initiation event either by a lack of properly uridylylated VPg or an 
inability to form the three dimensional interaction between the 5’ NTR and the CRE(2C) that 
provides the template for the addition of the two uridine residues [86].  
Our initial hypothesis led with the assumption that the absolute minimal replication 
complex required for viability demanded that stemloop d in domain I remain intact. Our results 
herein show that this is not the case, but instead virus continues to replicate. This is an 
important distinction to make as the literature used to make our initial hypothesis believed that 
stemloop d was a critical structure to producing viable virus [87]. Based on our findings, we now 
know that the lack of stemloop d does not abolish the virus altogether.  
The current literature believes that one of stemloop d’s roles is the primary location for 
3CD to bind. To explain the significance of this interaction, we must recall the formation of the 
ternary complex, where PCBP2 binds stemloop b, and 3CD binds the adjacent stemloop d. If 
stemloop b is removed, a secondary location has been shown to bind PCBP2 in its place: the 
stretch of cytosine residues directly following the opposite side of stem a [88]. An alternate 
binding location for 3CD has yet to be hypothesized, but formation of the ternary complex 
allows the 5’ end of the viral genome to come into close proximity of the replication machinery 
bound to the CRE and the 3’ poly A tail. With an altered location for 3CD to bind the 5’ end of 
viral RNA, initiation is imperfect and cannot begin at the appropriate location let alone maintain 
the tertiary structure required to bring all necessary replicative proteins together. Subsequently, 
this type of replication argues a non-specific possibly random point of initiation, one where a 
uridylylated VPg is unnecessary. VPg must still be nucleotidylated [51] as it is the protein primer 
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required for 3D to begin polymerization, but the double uridine may be less important as Kim et 
al has shown that VPg (while still bound to the 5’ end of genomes of TD viruses) would not have 
been uridylylated in priming these genomes [79].  
We have shown that our mutated RNA is capable of producing virus and the end result 
still lacks the 5’ end of the genome. This begs the question: how does the viral RNA continue to 
replicate enough of the genome to produce viable progeny? Further characterization of the 
mutated virus created herein and not addressed by this study would be necessary to fully verify 
the presence of both infectious viral particles and the encapsidated RNA. This could be 
accomplished by 1.) multiple passages demonstrating infectivity 2.) western blotting using 
antibodies specific to enterovirus to show capsid formation with enteroviral specificity 3.) 
reverse transcription PCR using various primers capable of polymerizing the 5’ end before then 
sequencing the genome to look for changes. Assuming that the results mimic those shown in 
viruses lacking stem a, stemloop b, and stemloop c, the current replication model would need 
altering to account for the fact that 3CD has no place to bind and functionally attract the 3’ end. 
A lack of the first 50 nucleotides of the viral genome has shown that positive strand replication 
is greatly affected, but not halted; this is thought to be because 3CD still has a location to bind 
to the 5’ end and circularize the genome, but without the predicted location for 3CD to bind (as 
in TD78) it would seem that the genome either does not require circularization or 3CD has found 
a new point at which to bind. 
The continued replication of viruses with deletions to the 5’ end is not new. While the 
research and results herein is important, there is still much work to be done. Research in this 
field and particularly these viruses is extremely important as highlighted in Chapman et. al 2008 
[19]. It is interesting to think that a human with dilated cardiomyopathy or acute myocarditis 
may not be accurately diagnosed until autopsy without specifically looking for terminally 
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deleted enteroviruses, since they replicate at such a low level, making them much harder to 
detect. How many cases, heart-related or enteroviral related do not screen for this possibility 
and therefore are diagnosed incompletely? Research into terminally deleted viruses and 
potential sources of vaccination should be explored more fully. 
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